In connection with the Ordering Party’s application for co-financing of the project entitled “Research and development of an innovative therapy for diabetic retinopathy based on the utilization of a modern eye drop formulation” as part of the call for proposals in the SMART 2 path competition financed under the program: European Funds for a Modern Economy (FENG) by the Polish Agency for Enterprise Development (PARP) („Project”),
Pikralida sp. z o.o. invites you to submit an offer for an expert advisory services in the field of preclinical development of innovative medicinal products for human use, concerning in particular: a toxicological study area.
Bids should be submitted electronically to the following e-mail address: pricing_offers@pikralida.eu or via the competitiveness database (link below), in person, by post or by courier to the address of our registered office (date of receipt shall be considered) by the June 28th, 2023, until: 11:59 pm.
The request for proposal No. 62/2023 and template documents have been published in the Competitiveness Database: https://bazakonkurencyjnosci.funduszeeuropejskie.gov.pl/ogloszenia/163773